Bioconversion of milk with Bifidobacterium breve for treatment of allergic manifestions in infants
US9707258B2 · kind B2 · utility
0Cited by
2References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 2, 2008 |
| Grant date | Jul 18, 2017 |
| Priority date | — |
| Expiry date | May 30, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2400/519
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of a Bifidobacterium strain for the preparation of compositions, in particular of an infant formula, intended for the prevention and/or treatment of allergic-type manifestations. These compositions are obtained from a Bifidobacterium culture, without hydrolyzing milk proteins. The bacteria, which preferably belong to the species Bifidobacterium breve, may be killed or removed from the composition during the process.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.